Code Biotherapeutics
-
Hatfield Biotechnology Startup Raises $75M to Develop Genetic Medicines
Recently Hatfield-based Code Biotherapeutics raised $75 million to develop genetic medicines that are based on technology aimed at increasing the…
-
Hatfield-based Code Biotherapeutics Enters Collaboration Deal with Takeda Potentially Worth $2B
Hatfield-based Code Biotherapeutics has entered into a collaboration and option deal with Takeda with a potential value of $2 billion,…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
